Skip to main content
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.6296
-0.0144 (-2.24%)
At close: Dec 5, 2025, 4:00 PM EST
0.6025
-0.0271 (-4.30%)
After-hours: Dec 5, 2025, 7:56 PM EST

Revenue by Product

Fiscal year is April - March.
Year Ending
 Mar '23 Mar '22 Mar '20 Mar '19
ViraxClear and ViraxVet
156.42K
Log In
Log In
Log In
ViraxClear and ViraxVet Growth
1727.11%
Log In
Log In
Log In
ViraxClear and ViraxCare
-
Log In
Log In
Log In
Consulting
-
Log In
Log In
Log In
Consulting Growth
-
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Year Ending
 Mar '23 Mar '22 Mar '20 Mar '19
United Kingdom, Hong Kong, Singapore, China, British Virgin Islands
156.42K
Log In
Log In
Log In
United Kingdom, Hong Kong, Singapore, China, British Virgin Islands Growth
1727.11%
Log In
Log In
Log In
Singapore
-
Log In
Log In
Log In
British Virgin Island
-
Log In
Log In
Log In